Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China (Q37379483)

20 August 2017

Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China (English)

1 reference

20 August 2017

0 references

Yu-Ye Li

1 reference

20 August 2017

Yong-Mei Jin

1 reference

20 August 2017

Li-Ping He

1 reference

20 August 2017

Jin-Song Bai

1 reference

20 August 2017

Jun Liu

1 reference

20 August 2017

Min Yu

1 reference

20 August 2017

Jian-Hua Chen

1 reference

20 August 2017

Jing Wen

1 reference

20 August 2017

Yi-Qun Kuang

1 reference

20 August 2017

language of work or name

English

0 references

publication date

31 October 2016

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

35938

1 reference

Creative Commons Attribution 4.0 International

20 August 2017

start time

31 October 2016

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Efficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

The Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Adverse cutaneous reactions to antimicrobials in patients with human immunodeficiency virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Drug reactions in HIV/AIDS

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Epidemiology of cutaneous adverse drug reactions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Immunologic tolerability profile of celecoxib

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Abacavir-induced liver toxicity in an HIV-infected patient

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Cutaneous adverse reactions to sulfonamide antibiotics.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

The changing face of HIV in China

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Clinical and immunogenetic correlates of abacavir hypersensitivity

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Cutaneous disease and drug reactions in HIV infection

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086857

Electronic structure of the iron-based superconductor LaOFeP.

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSREP35938

Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSREP35938

Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China

21 January 2018

1 reference

12 December 2020

Clinical Analysis of Skin Lesions in 796 Chinese HIV- positive Patients

1 reference

12 December 2020

Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases

1 reference

12 December 2020

AIDS and HIV infection in China

1 reference

12 December 2020

Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes f

1 reference

12 December 2020

Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/SREP35938

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

27796328

1 reference